Skip to content
MedGadget – Medical Technology and Healthcare News Website Logo

MedGadget

Where Medicine Meets Technology

  • Author
  • Contact Us
  • About Us
Top Stories
Vetter Expands Commercial Fill-and-Finish Capacity with Ten New Manufacturing Lines
Vetter Expands Commercial Fill-and-Finish Capacity with Ten New Manufacturing Lines
Bristol Myers Squibb Q3 2026 results graphic about pipeline data
Posted inPharmaceutical

Bristol Myers Squibb Q3 2026 Results: What the Pipeline Data on CELMoDs and Admilparant Show

The Bristol Myers Squibb Q3 2026 results include CELMoD, admilparant and RYZ101 updates. What each result shows and what is pending.
Continue Reading
October 30, 2026
Laurus Labs Galenvs acquisition graphic about oligonucleotide technology
Posted inBio Technology

Laurus Labs Galenvs Acquisition: The Oligonucleotide and Nanoparticle Technology Behind the Deal

The Laurus Labs Galenvs acquisition buys oligonucleotide and nanoparticle skills. What the technology involves and what is not shown.
Continue Reading
October 30, 2026
Fortis Healthcare acquisition graphic about care quality in Bengaluru
Posted inHealthcare Services

Fortis Healthcare Acquisition of Suguna Hospital: What Consolidation Means for Care Quality in Bengaluru

The Fortis Healthcare acquisition adds 110 beds in north-west Bengaluru. What evidence says about hospital deals and quality.
Continue Reading
October 30, 2026
Top Categories
Healthcare IT
Healthcare IT
Medical Device
Medical Device
Pharmaceutical
Pharmaceutical
Tecentriq stage III dMMR colon cancer: 36-month disease-free survival 86% versus 76% in the ATOMIC trial
Posted inPharmaceutical

FDA Approves Tecentriq Combination for Stage III dMMR Colon Cancer

Tecentriq stage III dMMR colon cancer approval: FDA clears atezolizumab plus chemotherapy, with 36-month disease-free survival of 86% vs 76%.
October 12, 2026
QIAstat-Dx bloodstream infection panels: results in about one hour, 33 pathogen targets and 28 resistance markers
Posted inMedical Device

QIAGEN Expands QIAstat-Dx Bloodstream Infection Testing in the US With New Gram-Negative Panel

QIAstat-Dx bloodstream infection portfolio is complete in the US as QIAGEN wins FDA clearance for a gram-negative panel with 18 resistance markers.
October 12, 2026
AI-powered surgical software market growing from $1.75B in 2025 to $24.55B by 2035
Posted inMedical Device

AI-Powered Surgical Software Market to Reach $24.55 Billion by 2035 at 30.2% CAGR

The AI-powered surgical software market is forecast to grow from $1.75B in 2025 to $24.55B by 2035 at a 30.2% CAGR, per Acumen Research.
October 10, 2026
Graphic: FDA accepts Bayer KERENDIA sNDA for chronic kidney disease without diabetes, with FIND-CKD Phase 3 data chips
Posted inPharmaceutical

FDA Accepts Bayer KERENDIA Application for CKD Without Diabetes

The FDA accepted Bayer’s application to extend KERENDIA to adults with chronic kidney disease without diabetes. FIND-CKD results, risks and next steps.
October 9, 2026
Graphic: Ribo RBD3133 INHBE-silencing siRNA for obesity with a DNA helix and EU Phase 1 filing label
Posted inBio Technology

Ribo Files EU Trial Application for Obesity siRNA RBD3133

Ribo has filed an EU application for a Phase 1 trial of RBD3133, an INHBE-targeting siRNA for obesity. What the gene evidence shows and what is unknown.
October 9, 2026
Graphic: Andelyn Biosciences in the US linked through PQP to EU and UK clinical sites for gene therapy supply
Posted inBio Technology

Andelyn Biosciences and PQP Group Partner on EU and UK Gene Therapy Supply

Andelyn Biosciences and PQP Group will coordinate EU and UK supply of US-made cell and gene therapies, from QP release to import and depot. How it works.
October 9, 2026
Graphic: Systech ST15S and ST16P pharmaceutical packaging stations above cartons with barcodes on a conveyor line
Posted inPharmaceutical

Systech Launches ST15S and ST16P Pharma Packaging Stations

Systech launches ST15S and ST16P stations that combine serialization, aggregation and labelling for drug makers and CDMOs. What they do, what is unknown.
October 9, 2026
Graphic: Neurosterix NTX-253 M4 modulator completes Phase 1 for schizophrenia, with Phase 1 marked complete and Phase 2 next
Posted inPharmaceutical

Neurosterix Completes Phase 1 of NTX-253, an M4 Drug for Schizophrenia

Neurosterix completed Phase 1 of NTX-253, an oral M4 modulator for schizophrenia, and plans Phase 2. What was tested and what is not yet public.
October 9, 2026
Graphic: Lakewood-Amedex Nu-8 reduced E. coli by up to 97 percent in a rodent urinary tract infection model
Posted inPharmaceutical

Lakewood-Amedex Reports Positive Preclinical Data for Bisphosphocin Antimicrobials

Lakewood-Amedex reports preclinical Bisphosphocin data in urinary and lung infection models, including up to 97% E. coli reduction in rodents.
October 8, 2026
Timeline graphic: Axplora European exatecan supply, validation batches end 2026, registration 2027, GMP supply late 2027
Posted inPharmaceutical

Axplora Advances Axotecan to Establish European Exatecan Supply for ADC Developers

Axplora completes first R&D batches of exatecan, an ADC payload starting material, aiming for European GMP supply by late 2027.
October 8, 2026

Posts pagination

Previous page 1 … 10 11 12 13 14 … 25 Next page

All Categories

  • Bio Technology
  • Healthcare IT
  • Healthcare Services
  • Life Science
  • Medical Device
  • Pharmaceutical
  • Press Releases
  • Uncategorized
Press Releases
Vetter Expands Commercial Fill-and-Finish Capacity with Ten New Manufacturing Lines
Posted inPress Releases

Vetter Expands Commercial Fill-and-Finish Capacity with Ten New Manufacturing Lines

Firefly Neuroscience and NeuroSigma Expand Access to Non-Drug Pediatric ADHD Treatment
Posted inPress Releases

Firefly Neuroscience and NeuroSigma Expand Access to Non-Drug Pediatric ADHD Treatment

InSilicoTrials Joins ARPA-H CIRCLE Program to Advance Digital Health Through Critical Care Digital Twins
Posted inPress Releases

InSilicoTrials Joins ARPA-H CIRCLE Program to Advance Digital Health Through Critical Care Digital Twins

Grünenthal and DKSH Expand Pain Medicine Partnership Across Eight Asia-Pacific Markets
Posted inPress Releases

Grünenthal and DKSH Expand Pain Medicine Partnership Across Eight Asia-Pacific Markets

Copyright 2026 — MedGadget.
Scroll to Top